Latest News – PSNC Main site
Pharmaceutical Services Negotiating Committee
MHRA Drug Safety Update July 2019
Date issued: 17th July 2019 A new Medicines and Healthcare products Regulatory Agency (MHRA) Drug Safety Update (Vol 12 Issue 12 July 2019) has been published and includes articles on: Febuxostat (Adenuric): increased risk of cardiovascular death and all-cause mortality in clinical trial in patients with a history of major cardiovascular disease Tocilizumab (RoActemra): rare...
Flu Vaccination Service: An update on vaccine supply
Public Health England, NHS England and NHS Improvement have issued a letter to general practices and community pharmacy contractors regarding the supply of quadrivalent flu vaccines. Manufacturers of quadrivalent flu vaccines have informed them that the delayed World Health Organization recommendation on vaccine strain has had an impact on their vaccine supply. Sanofi Pasteur has...
2020 Early May Bank Holiday change affects pharmacy opening requirements
The Government announced last month that it is pushing back next year’s Early May Bank Holiday by a few days to Friday 8th May 2020. The move has been made to coincide with the 75th anniversary of the Victory in Europe (VE) Day, which formally marked the end of World War II. Community pharmacies do not...
Contract Factsheet – Pharmacy opening hours in 2020
PSNC’s Regulations and Support Team are often asked questions about the requirements in the terms of service relating to opening hours. This briefing contains a quick reference guide for 2020. PSNC Briefing 025/19: Contract Factsheet – Pharmacy opening hours in 2020 (July 2019) If you have queries on this PSNC Briefing or you require more...
Shortage Notice: Nardil (phenelzine sulfate) 15mg tablets
Kyowa Kirin, the sole manufacturers of Nardil (phenelzine sulfate) 15mg tablets, are currently experiencing temporary disruptions. Kyowa Kirin, the main supplier of Nardil (phenelzine sulfate) 15mg tablets have advised a resupply date of end of October 2019 Supplies are available from specialist importers on an ‘unlicensed’ basis. Ensure that where a prescriber wishes you to...
Shortage Notice: Salbutamol 2mg/5ml syrup
GlaxoSmithKline (GSK) and Pinewood, the manufacturers of Salbutamol 2mg/5ml syrup, are currently experiencing temporary disruptions. GSK, the main supplier of Salbutamol 2mg/5ml syrup (Ventolin) have advised a resupply date of early August 2019 Pinewood are long term out of stock due to manufacturing issues and are currently unable to advise a resupply date. Supplies are...
July 2019 Price Concessions – 1st update
Department of Health and Social Care (DHSC) has today granted the following initial list of price concessions: Drug Pack size Price Concession Betahistine 8mg tablets 84 £1.37 Betahistine 16mg tablets 84 £2.50 Ibandronic acid 150mg tablets 1 £9.95 Losartan 12.5mg tablets 28 £3.82 Pantoprazole 40mg gastro-resistant tablets 28 £3.85 Prednisolone 5mg tablets 28 £2.25 Prednisolone...
Contractor Announcement: Category M prices to increase from August
After discussions with PSNC, Category M reimbursement prices will increase by £15 million a month from August 2019, the Department of Health and Social Care (DHSC) has confirmed. This is to correct a predicted shortfall in the margin delivery rate for the current financial year and it will be reviewed in the autumn. At the...
PSNC appoints Sue Killen as new chair
Sue Killen has been appointed as non-executive Chair of PSNC. Sue brings a wealth of experience from working in government and the third sector and will take up the post at PSNC on 1st September 2019. She replaces Sir Michael Pitt who will complete four years as Chair at the end of August. Sue previously...
CPPE Corner: Leadership – Building on your Mary Seacole award
The Centre for Pharmacy Postgraduate Education (CPPE) will be running leadership workshops for those who have already completed the Mary Seacole programme, and want to build further on their skills. Here we find out more about the workshops. Have you successfully completed the Mary Seacole programme for community pharmacy and are looking to continue to...
PharmaTimes: PharmaTimes Website RSS
PharmaTimes - The latest news in healthcare and life sciences - PharmaTimes Website RSS
Novartis’ sickle cell drug wins FDA priority review
The governing body accepted the company's Biologics License Application for prevention of vaso-occlusive crises.
Gender imbalance expected in senior pharma roles until 2090
More than 85% of companies have no women executives on their main boards, only 9% of executive directors on main boards are women, and a mere 17% of FTSE350 executive committee members are women.
Boots UK to offer cystitis test
During the pilot over the last seven months over 1,000 customers accessed the service, with the majority of them completing the service in the same day.
‘World’s most accurate blood test’ launched in UK
The Mitomic Prostate Test has a 92% sensitivity, which means that men with a positive result can be referred for immediate medical intervention.
PureTech acquires LYT-100 to treat lymphedema
The candidate, LYT-100, demonstrated anti-fibrotic and anti-inflammatory mechanisms in pre-clinical studies.
Boehringer enriches cancer immunology portfolio with AMAL Therapeutics acquisition
AMAL’s lead vaccine, ATP128, is currently developed for stage IV colorectal cancer and is slated to begin first-in-human trials later this month.
Roche’s Genentech inks deal with Sosei Heptares
Under the terms of the agreement, Sosei Heptares is eligible to receive US$26 million in upfront and near-term payments.
NICE U-turn for Kisqali in breast cancer
NICE has recommended Novartis’ Kisqali just three months after its initial rejection.
Every sector of the pharmaceutical market is represented under one roof, this year in Madrid. Attending CPhI Worldwide is the most cost effective way to establish new business relationships, meet with global partners and stay updated on the latest industry trends.
Find out more: https://www.cphi.com/europe/